England’s NICE Says Severity Modifier Working, But Industry Wants Cost Restrictions Lifted

Cost Balance
The ABPI says the cost-neutrality restriction imposed on NICE should be lifted • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography